Like any test that boosts primary care revenue, this test is coming under fire.
Related posts:
- Tips for convincing your doctor to order more tests for you
- Revenue and e-messaging your patients
- Minimally invasive surgery via the vagina
- Can Sanjay Gupta be trusted?
- The controversy over organ donations after cardiac death
- EPO controversy
- Freebirth controversy
KevinMD.com on Facebook
{ 1 comment }
If a internits or FP uses revenue enhancing tools…why do they always attack it. Instead, provide results of whether the test is beneficial or not. Cost effective or not. Not, just because the PCP doctor makes money off it. Where’s the evidence for or against. The article is only full of hearsay, anecdotal stories, and N of one opinions. not facts. NYT, do your readers favor and educate, not pontificate.
Comments on this entry are closed.